by Brian Robertson “Trump really could empower RFK Jr. to wreck public health” proclaims the headline in Vox. “RFK Jr. Wants to Reshape US Health Policy. Good Luck With That” mocks a banner in Wired. Likewise, the Wall Street Journal joined the frenzy, noting that “industry, doctors, and their supporters in Congress probably will…
Read More
“A bun in the toaster oven,” a woman exclaims off-camera, handing an ultrasound image to family members who erupt into tearful emotion over the news. “Oh my God!”
The touching baby announcement video then gets down to business as text appears on the screen amidst the ongoing celebration, suggesting the best way to stay alive for this joyous birth is by becoming vaccinated against COVID-19. “Why will you get vaccinated? … Because some people you just want to meet in person.”
Read More
In Tennessee, the battle to protect pharmacy benefits is not merely a matter of policy, but a battle to protect our country from unnecessary government overreach by the extreme Left. I am deeply troubled by recent attempts at the federal level that target pharmacy benefits and our free market – all in one swoop.
People across our state are already experiencing immense financial strain as they grapple with the soaring costs of inflation and prescriptions, and we need to advocate for policies that will effectively lower these prices through free market competition.
Read More
Big Pharma is not your friend. Whether it’s hiking up drug prices or bribing the Swamp, the pharmaceutical industry works against the people’s interests. Many Americans are aware of Big Pharma’s greed and the power it wields over Washington, D.C., but fewer are aware of just how left-wing the industry is. It serves as a cash cow for the left and pushes woke ideas on its employees and the country at large. This may explain why Democrats, who act like they hate Big Pharma, serve the industry’s interests.
While the drugmakers spread their cash around all of DC, they overwhelmingly prefer Democrats. In recent elections, Big Pharma donated significantly more money to Democratic candidates than Republican candidates. From 2016 to 2022, the industry gave a whopping $29 million to Democratic candidates. This trend stands true for the current election cycle, with more cash going to Democrats once again. This favoritism extends to the presidential race. The drug lobby has donated four times more money to Joe Biden than it has to Donald Trump. And the industry’s generosity to Team Blue doesn’t end with individual candidates. Its chief lobby, PhRMA, also gives millions to liberal campaign arms like the Democratic Attorneys General Association.
Read More
Top pharmaceutical companies raised the list price on 775 brand-name drugs in just the first half of January, even as President Joe Biden aims to keep prices low, according to The Wall Street Journal.
The median price hike of the drugs was around 4.5%, with some rising by 10% or more, despite an inflation rate of 3.4% year-over-year in December, according to data from 46brooklyn Research acquired by the WSJ. The price hikes are in contrast to the president’s efforts to tame rising drug prices, taking actions such as imposing automatic rebates to Medicare for drugmakers that raise their prices faster than the price of inflation, which first went into effect in December, affecting 48 drugs covered under Medicare Part B.
Read More